Moreover, adding pimobendan to heart failure therapy in dogs with furosemide and angiotensin-converting enzyme inhibitors delayed the onset of refractory signs of heart failure, improved clinical conditions, and increased survival time [4–6]. Here, ACE is linked to heart failure.